Meet your enrollment goals faster by recruiting from Evidation’s
engaged, highly characterized health community.
Quickly connect the right participants to your trial
Related Posts
Long-Term Treatment with Kesimpta Shows Sustained Efficacy in Recently Diagnosed, Treatment-Naïve Patients with Relapsing MS
Image credit: Nathan Devery com | stock.adobe.com Results from the open-label ALITHIOS extension study demonstrated the long-term efficacy of first-line,…
Industry Assessment of Risk-Based Quality Management Emphasizes Value of Adoption
Image Credit: © Murrstock – stock.adobe.com The Tufts Center for the Study of Drug Development (Tufts CSDD), in collaboration with…
Vepdegestrant Granted FDA Fast Track Designation for ER-Positive/HER2-Negative Breast Cancer
Image credit: LASZLO | stock.adobe.com. The FDA has granted Fast Track designation to Arvinas’ and Pfizer’s vepdegestrant (ARV-471) monotherapy for…